Actively Recruiting
Evaluating HepQuant DuO Test as a Biomarker to Monitor Liver Recovery in Alcohol-related Liver Disease
Led by HepQuant, LLC · Updated on 2026-09-16
40
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying liver recovery in adults who have recently experienced alcohol-associated liver injury. The study aims to assess liver function and physiology using a blood-based test called the HepQuant DuO Test. This test involves drinking a natural compound called cholate and collecting two blood samples at 20 and 60 minutes. The goal is to collect clinical and laboratory data to improve monitoring and treatment for patients affected by alcohol-related liver disease. Participants will have four outpatient visits at 1, 3, 6, and 12 months after enrollment. At each visit, they will undergo the HepQuant DuO Test along with other standard tests. The study team will also ask questions about alcohol use, symptoms, and quality of life. The HepQuant DuO Test is an investigational device used to measure changes in liver function over time. During the study, participants will be monitored through blood tests and questionnaires about their health and alcohol habits. The main outcome measured is the change in the HepQuant Disease Severity Index DSI over one year. This helps researchers understand how liver function changes in patients with alcohol-related liver disease. The total participation period lasts for one year from enrollment.
CONDITIONS
Brief Title
Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here